Published in Lancet on April 08, 1989
Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science (2012) 2.26
Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol (2013) 1.70
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells. Clin Cancer Res (2009) 1.38
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant (2007) 0.88
Reconstitution of self-tolerance after hematopoietic stem cell transplantation. Immunol Res (2010) 0.84
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach. Biol Blood Marrow Transplant (2015) 0.83
Xenobiotics, chimerism and the induction of tolerance following organ transplantation. Ther Immunol (1994) 0.76
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells. Br J Cancer (2000) 0.76
A dominant role for non-MHC gene effects in susceptibility to cyclosporin A (CsA)-induced autoimmunity. Clin Exp Immunol (1998) 0.75
Four decades of glucocorticosteroid immunosuppression. CMAJ (1993) 0.75
Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma. Immune Netw (2013) 0.75
Potentiation of in vitro synthesis of human IgE by cyclosporin A (CsA). Clin Exp Immunol (1995) 0.75
Haematology. Postgrad Med J (1990) 0.75
Adoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparities. Proc Natl Acad Sci U S A (1992) 0.75
The prevalence of psychological distress by cancer site. Psychooncology (2001) 7.52
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature (1990) 4.62
Some practical improvements in the continual reassessment method for phase I studies. Stat Med (1995) 3.43
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
A new psychosocial screening instrument for use with cancer patients. Psychosomatics (2001) 2.81
Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol (1997) 2.74
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2002) 2.69
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology (2007) 2.54
Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med (1995) 2.50
Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med (1999) 2.47
Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47
Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc (1967) 2.44
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts. Transfusion (1990) 2.33
A randomized controlled trial comparing the cuffed oropharyngeal airway and the laryngeal mask airway in spontaneously breathing anesthetized adults. Anesthesiology (1998) 2.33
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol (2001) 2.32
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer (1990) 2.28
Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28
DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A (1993) 2.27
Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol (1994) 2.24
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science (1985) 2.17
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol (1985) 2.05
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology (1995) 2.00
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res (1997) 1.94
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol (1997) 1.86
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood (1989) 1.85
Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol (1979) 1.84
Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol (1997) 1.81
The utility of submitting fibroepithelial polyps for histological examination. Arch Dermatol (1996) 1.79
The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol (1973) 1.78
Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer (1982) 1.77
Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res (1991) 1.76
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 1.72
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer (1984) 1.71
DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol (1998) 1.71
Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res (1999) 1.69
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res (2001) 1.68
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol (1990) 1.65
Development of a prognostic model for grading chronic graft-versus-host disease. Blood (2001) 1.65
Cyclosporin A and the thymus. Immunopathology. Am J Pathol (1987) 1.65
Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
Spinal cord stimulation for chronic, intractable pain: superiority of "multi-channel" devices. Pain (1991) 1.63
Microsatellite instability at AAAG repeat sequences in respiratory tract cancers. Int J Cancer (2001) 1.62
Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg (1989) 1.60
Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med (1988) 1.59
The diagnostic yield of histologic examination of seborrheic keratoses. Arch Dermatol (1997) 1.59
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol (1997) 1.58
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res (1997) 1.58
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55
Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol (1994) 1.55
Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Cancer (1999) 1.52
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage (1991) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol (1994) 1.50
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Immunosuppressive drugs. Pharmacol Rev (1970) 1.48
Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation. Bone Marrow Transplant (1992) 1.48
The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. J Invest Dermatol (1983) 1.48
DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J Invest Dermatol (1995) 1.47
High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases. Bone Marrow Transplant (2003) 1.46